JAMA Internal Medicine 'Under Review': What Each Status Means
If your JAMA Internal Medicine submission shows Under Review, here is what JAMA Network editors are doing during each stage and when to follow up.
While you wait
Waiting on a decision? Get your next move ready.
The wait is out of your hands; the next move isn't. Scan your next manuscript free, or run this paper through the scan to see what reviewers typically push back on, so the revision response is ready when the decision lands.
Last reviewed: 2026-05-16.
Quick answer: If your JAMA Internal Medicine submission shows "Under Review," elapsed time is the most reliable signal. JAMA Internal Medicine has a 2025 Journal Impact Factor of 26.3 in the 2026 JCR release, and reports a median time to first decision of 1 day without external peer review and 33 days with review (per the journal's For Authors page, updated July 2026).
The journal's 2025 Year in Review reports medians of 1 day without peer review and 35 days with peer review for calendar year 2025, a 12% overall acceptance rate and 4% for original research. These are journal-level figures and do not predict one manuscript's timeline.
For a second opinion before reviewers see your manuscript, run a JAMA Internal Medicine submission readiness check.
What submission portal does JAMA Internal Medicine use?
JAMA Internal Medicine uses its own online manuscript submission and review system at JAMA Internal Medicine manuscript system, the address named on the journal's For Authors page and in its Instructions for Authors. Editorial questions should reference the manuscript ID, and the journal's For Authors page links to the Instructions for Authors and the submission system.
Authors can check the status of a submitted manuscript in that system. The journal's masthead lists Statistical Editors, and the instructions set expectations for statistical methods, but they do not say which manuscripts are routed to statistical review or how many reviewers are invited.
How JAMA Network handles a JAMA Internal Medicine submission
JAMA Internal Medicine's instructions say all submitted manuscripts are reviewed initially by one of the editors. Manuscripts are evaluated against these criteria: material is original and timely, writing is clear, study methods are appropriate, data are valid, conclusions are reasonable and supported by the data, information is important, and the topic has general interest to readers of the journal. Manuscripts with insufficient priority for publication are rejected promptly, and the others are sent to expert consultants for peer review. The journal's For Authors page reports a median of 1 day to first decision for manuscripts not sent for external peer review.
The journal's For Authors page reports a 9% acceptance rate for all submissions and a median of 1 day to first decision without external peer review. A manuscript that is sent for external review has passed the editors' first read.
What are the JAMA Internal Medicine review statuses?
Status labels appear only inside the logged-in submission system, so the table describes what may be happening, not a published definition.
Status | What may be happening | Published timing |
|---|---|---|
Submitted | Receipt and file checks; authors are sent notification of receipt by email | No published figure |
With Editor | An editor reads the manuscript first and decides whether to reject it promptly or send it to expert consultants | Median 1 day to first decision without external peer review (For Authors page, updated July 2026) |
Statistical Review | Statistical methods may be examined; the instructions do not say which manuscripts are routed to statistical review | No published figure |
Under Review | External reviewers invited or actively reviewing | Median 33 days to first decision with review (For Authors page, updated July 2026) |
Reports Received | An editor weighing returned reports | No published figure |
Decision Sent | Reject, revise, or accept | Check email (authors are sent editorial decisions by email) |
The editor desk screen
Before the paper reaches external reviewers, one of the editors reads it against the criteria in the instructions, including whether the topic has general interest to readers of the journal. The journal reports a 9% acceptance rate for all submissions and a median of 1 day to first decision without external peer review (For Authors page, updated July 2026), but it does not publish what share of submissions are rejected at this stage or the reasons for desk rejection. At submission, authors may choose to have a manuscript that is not accepted referred, with reviewers' comments if available, to one of the JAMA Network specialty journals and/or JAMA Network Open.
What should the JAMA Internal Medicine submission package include?
The instructions do not describe a separate administrative-check stage, so use them as the submission requirements: the manuscript file with title page, abstract, text, references, and as appropriate figure legends and tables, with figures that may be embedded at the end of the file for initial submission; reporting checklists where applicable (CONSORT for clinical trials, STROBE for observational studies, PRISMA for systematic reviews, STARD for diagnostic-accuracy studies, SQUIRE for quality-improvement reports); a cover letter with the corresponding author's contact details and any related papers from the same study; the Authorship Form with conflict-of-interest disclosures; institutional review board or ethics committee approval or waiver for studies involving human participants or animals; trial registration (JAMA Network requires registered clinical trials); and the trial protocol with the statistical analysis plan for clinical trials.
What does With Editor mean at JAMA Internal Medicine?
One of the editors reads the paper first. The criteria in the instructions are originality and timeliness, clear writing, appropriate study methods, valid data, conclusions supported by the data, importance, and general interest to readers of the journal. The For Authors page reports a median of 1 day to first decision without external peer review.
What does statistical review mean at JAMA Internal Medicine?
The journal's masthead lists Statistical Editors, and the Statistical Methods and Data Presentation section of the instructions sets expectations for prespecified primary outcomes, secondary and subgroup analyses, and reporting standards. The instructions do not say which manuscripts are routed to statistical review, whether it runs in parallel with peer review, or how long it takes.
How does JAMA Internal Medicine recruit reviewers?
The instructions say manuscripts that are not rejected promptly are sent to expert consultants for peer review; they do not state how many reviewers are invited. At journals in general, common delay causes during recruitment include slow reviewer recruitment for specialized topics and split reviewer opinions requiring additional reviewers.
How long is active peer review at JAMA Internal Medicine?
The For Authors page reports a median of 33 days to first decision with review (updated July 2026), and the 2025 Year in Review reports 35 days for calendar year 2025. The journal does not publish a per-reviewer turnaround or the questions reviewers are asked to apply.
What happens after JAMA Internal Medicine receives reviews?
After reports return, an editor weighs them; the instructions say final decisions regarding manuscript publication are made by the editor in chief or a designated editor who does not have any relevant conflicts of interest. The 33-day median to first decision with review is a journal-level figure, not a promise for one manuscript.
When to worry
- Rejection within 1 to 3 days: Probably an editor's first-read decision. The journal reports a median of 1 day to first decision without external peer review.
- Rejection within 1 to 2 weeks: Probably still an editor's decision, since it comes before the 33-day median for decisions with review; the journal does not publish reasons.
- Still Under Review after 3 weeks: The paper is well past the 1-day median for decisions without external peer review, so it is probably in external review.
- Still Under Review after 8 weeks: Reviewer-recruitment or reviewer-report delay despite the 33-day median. A polite inquiry via the submission portal is appropriate.
- Status changes to "Reports Received": Reports may be in; the journal publishes no timing for the next step.
"My paper has been Under Review for 5 weeks. Is that bad?"
This is the most common anxiety we hear from JAMA Internal Medicine authors during the active editorial window. The honest answer: no, 5 weeks at Under Review is close to JAMA Internal Medicine's reported median of 33 days to first decision with review, and a median means roughly half of those decisions take longer. Reports may already be in editorial synthesis with an editor preparing a recommendation. Most reviewer-driven delays come from reviewer-recruitment timing for internal-medicine specialists rather than slow reviews.
If the portal still says Under Review at the 7-week mark, common explanations at journals are that a reviewer asked for an extension or that an editor invited an additional reviewer to break a split opinion; the journal does not publish how often either happens.
What you should NOT do during the 5-to-7-week window is email the editorial office. An inquiry at 5 weeks adds friction without accelerating the timeline.
What to do while waiting
- Do not contact the editorial office during the first 6 weeks unless an urgent ethics issue surfaces.
- Do not submit the paper anywhere else while it is Under Review at JAMA Internal Medicine. JAMA Network has explicit prohibitions on dual submission.
- Prepare a point-by-point response template for likely reviewer concerns: trial-design rigor, CONSORT/STROBE-compliance documentation, statistical-analysis pre-specification, broad-internal-medicine framing.
- If you have related work submitted elsewhere or recently published, prepare disclosure language for when revisions are requested.
- Read recent JAMA Internal Medicine papers in your subfield to calibrate the current editorial bar.
Readiness check
While you wait, scan your next manuscript.
The scan takes about 2 to 3 minutes. Use the result to decide whether to revise before the decision comes back.
If JAMA Internal Medicine rejects: sister-journal cascade with reasoning
If your JAMA Internal Medicine paper is rejected after review, the natural cascade depends on what the reviewers and deputy editor cited:
JAMA Network Open is the most natural JAMA Network cascade because the instructions say that, at submission, authors may choose to have manuscripts that are not accepted referred to one of the JAMA Network specialty journals and/or JAMA Network Open along with reviewers' comments (if available). JAMA Network Open has a broader scope and an open-access publishing model.
JAMA is the JAMA Network cascade option for papers with broad-clinical-impact that exceeds the internal-medicine subspecialty scope. JAMA's review process is similar but with even higher selectivity.
Annals of Internal Medicine is the ACP cascade option for internal-medicine papers where the ACP clinical-practice focus fits. ACP operates independently; reports do not transfer, but Annals editors may recognize JAMA Network reviewer reports informally.
BMJ is the BMJ cascade option for broad-medical papers with international clinical-practice implications. BMJ operates independently with its own reviewer pool.
How JAMA Internal Medicine compares to nearby alternatives
Feature | JAMA Internal Medicine | Annals of Internal Medicine | BMJ | JAMA |
|---|---|---|---|---|
Desk-rejection rate | 78% rejection without review (2017) | about 55% not sent out for review (journal page, read October 2026) | about two thirds rejected without external peer review (as archived in December 2017) | 73.4% not sent out for review (2016) |
Desk-decision speed | 1-day median without external peer review | 1 to 3 weeks | 1 to 3 weeks | 2 days to first decision without review (publisher figure) |
Total review time (post-screen) | 33-day median to first decision with review | 6 to 10 weeks | 6 to 10 weeks | 6 to 10 weeks |
Reviewer count | Not published | 2 to 3 + statistical reviewer | 2 to 3 | 2 to 3 + statistical reviewer |
Statistical review | Statistical Editors listed on the masthead | Methodology review | Statistical methods review | In-house statistical reviewer (JAMA Network) |
Editorial bar | Top internal medicine + JAMA Network rigor | Top internal medicine + ACP practice fit | Top general medical + international | Top general medical + JAMA flagship |
Submit If
If your JAMA Internal Medicine paper is Under Review past 1 week, it has probably cleared the editors' first read. Use the waiting window to prepare a thorough revision response template.
JAMA Internal Medicine submission readiness check takes about 5 minutes.
Think Twice If
JAMA Internal Medicine editors make the final decision on every manuscript and can reject after review if reviewer reports surface methodological or broad-significance concerns the first read did not catch. The masthead lists Statistical Editors, so statistical weaknesses are worth fixing before submission. Be especially cautious if:
- The abstract describes a narrow specialty outcome but does not state the broad internal-medicine decision, population, or practice implication.
- The manuscript CONSORT, STROBE, PRISMA, STARD, trial registration, statistical analysis plan, endpoint hierarchy, or data-availability table is incomplete.
- The manuscript methods section mixes post-hoc analyses with prespecified analyses, leaves missing-data handling vague, or frames subgroup findings more strongly than the design supports.
For a pre-upload diagnostic of trial-design rigor and broad-internal-medicine framing, run a JAMA Internal Medicine pre-submission diagnostic before reviewer reports surface those concerns.
This guide tells you what JAMA Internal Medicine editors look for during the status window. Manusights has reviewed 50+ manuscripts targeting JAMA Internal Medicine or adjacent clinical-medicine venues; full Manusights reviews include a 60-day money-back guarantee, and we do not train AI on customer manuscripts.
Last verified: JAMA Internal Medicine author guidance at Jamanetwork author instructions and JAMA Network editorial documentation.
JAMA Internal Medicine Pre-Decision Checklist
- Reframe the abstract around the internal-medicine decision the paper changes, not only the disease area or statistical result.
- Attach the correct reporting package: CONSORT, STROBE, PRISMA, STARD, SQUIRE, trial registration, SAP, IRB statement, data-sharing statement, and supplement where relevant.
- Separate prespecified, exploratory, post-hoc, subgroup, and sensitivity analyses before reviewers or statistical editors ask.
- Prepare a response table for broad clinical importance, statistical methods, missing data, endpoint hierarchy, and patient-centered interpretation.
- Compare JAMA Internal Medicine against JAMA, JAMA Network Open, Annals of Internal Medicine, BMJ, and specialty JAMA titles before assuming the first rejection route is the right cascade.
The JAMA Internal Medicine reviewer experience
The instructions for authors do not publish the questions reviewers are asked. The criteria they state for the editors' own first read are originality and timeliness, clear writing, appropriate study methods, valid data, conclusions supported by the data, importance, and general interest to readers. The table below maps four preparation areas to those criteria and to the statistical-methods expectations in the instructions.
Reviewer focus area | What a reviewer is likely to look for | How to prepare for it |
|---|---|---|
Broad internal medicine significance | Could this finding change internal-medicine practice or substantively advance clinical understanding? | Frame the abstract and discussion around the specific clinical decision this paper affects. CONSORT/STROBE reporting compliance is required. |
Trial design and rigor | Is the trial design appropriate, pre-registered, and reported per CONSORT (trials), STROBE (observational), PRISMA (systematic reviews), STARD (diagnostic)? | Attach the relevant reporting checklist; address pre-registration deviations explicitly. Include statistical analysis plan as supplementary file. |
Statistical methodology | Are statistical methods appropriate, pre-specified, and clearly reported? | Have a statistician on the author team review before submission. The masthead lists Statistical Editors. |
Reproducibility | Could another team interpret these methods and data consistently? | Use detailed methods documentation. JAMA Network requires a Data Sharing Statement for research articles. For trials, deposit individual-participant data where possible. |
What we see in our pre-submission review work on JAMA Internal Medicine manuscripts
Across JAMA Internal Medicine manuscripts, three patterns generate the most consistent reviewer concerns we see. JAMA Internal Medicine failures are usually not about whether the study is clinically interesting at all. They are about whether the paper proves broad internal-medicine relevance, documents the reporting and statistical package, and distinguishes prespecified claims from exploratory signals.
CONSORT/STROBE-compliance gaps surface as reviewer requests for clarification. When reporting-checklist items are incomplete or trial-pre-registration alignment is unclear, reviewers consistently flag for revision. The strongest revisions add complete reporting-checklist documentation with pre-registration alignment.
Statistical analysis plan under-documented. When the pre-specified statistical analysis plan is thin or post-hoc analyses are not clearly distinguished from pre-specified analyses, reviewers consistently request expanded methods documentation.
Broad-internal-medicine significance under-stated in framing. When the abstract and discussion do not clearly establish the broad-clinical decision that would change, deputy editors and reviewers flag general-clinical-interest concerns. The strongest manuscripts frame the abstract around the specific internal-medicine decision the paper affects.
Check whether your JAMA Internal Medicine abstract shows broad clinical relevance ->
Check whether your JAMA Internal Medicine reporting package is complete ->
Check whether your JAMA Internal Medicine statistical analysis language is aligned ->
The first repeated failure is an abstract that sounds like a specialty-journal abstract. A strong internal-medicine paper can come from cardiology, oncology, infectious diseases, endocrinology, geriatrics, primary care, or health policy, but the first paragraph still has to tell a general internal-medicine reader why the result changes a decision they recognize. We often see manuscripts that save that statement for the discussion, where it arrives too late for a deputy editor's first read.
The second failure is statistical-package incompleteness. Statistical weaknesses can override favorable clinical interest if the trial registration, SAP, endpoint hierarchy, missing-data plan, multiplicity handling, or subgroup language is not aligned. The most efficient pre-decision work is to build a table that connects every major result to prespecification status, analysis population, missing-data treatment, and sensitivity analysis.
The third failure is overclaiming exploratory results. JAMA Internal Medicine reviewers are receptive to clinically meaningful signals, but they scrutinize whether the title, abstract, visual abstract, discussion, and conclusion distinguish primary, secondary, exploratory, and post-hoc findings. Stronger manuscripts keep the clinical implication honest while still making the patient or practice relevance unmistakable.
Methodology note
This page was created from JAMA Network's public author guidance at Jamanetwork author instructions, JAMA Network editorial-process documentation, JAMA Internal Medicine first-decision data (1-day median without external peer review, 33 days with review, from the For Authors page updated July 2026), and Manusights pre-submission review experience with JAMA Internal Medicine-targeted manuscripts.
Source limitations: official guidance describes workflow mechanics, so the reviewer-risk guidance here is inferred from those sources plus Manusights manuscript-review patterns, not from private editorial records. In Manusights' manuscript-review archive, 50+ clinical, internal-medicine, public-health, and trial manuscripts turned on broad clinical framing, statistical-documentation completeness, or reporting-package readiness rather than the submission-system status label itself.
What to read next
For the JAMA Network internal-medicine landscape beyond JAMA Internal Medicine, compare JAMA, JAMA Network Open, Annals of Internal Medicine, BMJ, and JAMA specialty titles such as JAMA Cardiology and JAMA Oncology. The choice across these titles depends on whether the central contribution is broad internal medicine, broader clinical medicine, open access, ACP practice fit, international general medicine, or subspecialty-focused.
The journal does not publish reviewer composition. Preparing a response template that addresses both the clinical and the methodological perspective accelerates revision rounds substantially.
For a pre-upload check of your manuscript against the JAMA Internal Medicine broad-significance-plus-statistical-rigor bar before submission, our JAMA Internal Medicine pre-submission diagnostic flags the CONSORT/STROBE-compliance gaps and statistical-methodology weaknesses most likely to surface in reviewer reports.
Frequently asked questions
The manuscript is in the journal's editorial or external-review workflow. The instructions say every submitted manuscript is read first by one of the editors, and manuscripts that are not rejected promptly are sent to expert consultants for single-anonymized peer review. The journal's masthead lists Statistical Editors, but the instructions do not say which manuscripts are routed to statistical review.
The journal's For Authors page (updated July 2026) reports a median time to first decision of 1 day without external peer review and 33 days with review. The 2025 Year in Review reports 1 day and 35 days for calendar year 2025. These are journal-level medians, not a forecast for one manuscript.
Wait at least 8 weeks before inquiring. The journal does not publish an inquiry schedule, so check the status in the online manuscript submission and review system first and reference the manuscript ID if you write.
No. JAMA Internal Medicine reports a 33-day median to first decision with review, so 5 weeks is close to the journal's median. Reports may already be in editorial synthesis.
Your paper may have passed the editors' first read and reviewers may have been invited. The journal does not publish how many reviewers it invites or which manuscripts receive statistical review.
Yes. The 33-day median with review is a journal-level median for first decisions, so some decisions take longer, and the journal publishes no figure for revision rounds. Common delay causes include slow reviewer recruitment for specialized topics, split reviewer opinions requiring additional reviewers, and revision cycles.
Past 10 weeks is the right moment for a polite inquiry. Past 14 weeks may mean a reviewer is late or has dropped out. Silence in the first 6 weeks is common.
Sources
Free guide
Waiting is not the same as being ignored, and there is a way to tell.
Reviewers usually get ten days. When it has been months, an appeal and a complaint are different instruments with different addresses, and only one of them fits a delay. This is which to use, and the wording that gets an answer.
Final step
Done interpreting the status? Put the wait to work.
The decision will arrive on the journal's clock. What you control is what's next: scan your next manuscript free, or run this paper through the scan so the likely reviewer pushback is mapped before the revision request lands.
Free scan, no card needed.
Private API processing. Your manuscript is not used to train models.
Re-read the status guidePut the guidance to work
Turn a decision into a clear next step.
Use the practical response workflow when a manuscript needs revision, or the process guide when you need to understand what the editorial status means.
Where to go next
Start here
Same journal, next question
- JAMA 'With Editor': What the Editorial Screen Means
- JAMA Internal Medicine Impact Factor 2026: 26.3 (2025 JIF)
- JAMA Response to Reviewers: How to Write a Rebuttal That Wins (2026)
- JAMA APC and Open Access: Two Journals, One Fee, and How to Get Coverage
- Rejected from JAMA? The 7 Best Journals to Submit Next